CoChat

The accuracy of cystatin C and commonly used creatinine‐based methods for detecting moderate and mild chronic kidney disease in diabetes

MacIsaac, R. J., Tsalamandris, C., Thomas, M. C., Premaratne, E., Panagiotopoulos, S., Smith, T. J., Poon, A., Jenkins, M. A., Ratnaike, S. I., Power, D. A., Jerums, G. · 2007 · Diabetic Medicine
Cited by 56

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background The accuracy of measuring serum cystatin C levels for detecting various stages of chronic kidney disease (CKD) in diabetes is still unclear. Methods In a cross‐sectional study of 251 subjects, a reference glomerular filtration rate (GFR) was measured using 99c Tc‐DTPA plasma clearance (iGFR). Multivariate analysis was used to identify independent clinical and biochemical associations with serum cystatin C and iGFR levels. The diagnostic accuracy of cystatin C and commonly used creatinine‐based methods of measuring renal function (serum creatinine, the MDRD four‐variable and Cockcroft–Gault formulae) for detecting mild and moderate CKD was also compared. Results In the entire study population the same five variables, age, urinary albumin excretion rates, haemoglobin, history of macrovascular disease and triglyceride levels were independently associated with both cystatin C and iGFR levels. A serum cystatin C level cut‐off > 82.1 nmol/l (1.10 mg/l) had the best test characteristics as a screening tool for detecting moderate CKD (< 60 ml/min per 1.73 m 2) when compared with creatinine‐based methods. At the upper threshold for mild CKD (< 90 ml/min per 1.73 m 2), cystatin C also had greater diagnostic accuracy than creatinine, but had similar diagnostic accuracy when compared with creatinine‐based formulae for predicting renal function. Conclusions This study suggests that the clinical and biochemical parameters associated with serum cystatin C levels are closely linked to those associated with GFR and highlights the potential usefulness of screening for moderate or mild CKD in subjects with diabetes by simply measuring serum cystatin C levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2007.02112.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 56

Metadata

Authors
MacIsaac, R. J., Tsalamandris, C., Thomas, M. C., Premaratne, E., Panagiotopoulos, S., Smith, T. J., Poon, A., Jenkins, M. A., Ratnaike, S. I., Power, D. A., & Jerums, G.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2007-03-21
Volume
24
Issue
4
Pages
443-448
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2040558144
Cited by
56
References
2
FWCI
5.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The accuracy of cystatin C and commonly used creatinine‐based methods for detecting moderate and mild chronic kidney disease in diabetes. https://app.cochat.ai/papers/10.1111/j.1464-5491.2007.02112.x
The paper
MacIsaac, R. J., Tsalamandris, C., Thomas, M. C., Premaratne, E., Panagiotopoulos, S., Smith, T. J., Poon, A., Jenkins, M. A., Ratnaike, S. I., Power, D. A., & Jerums, G. (2007). The accuracy of cystatin C and commonly used creatinine‐based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2007.02112.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.